Opinion ID: 212733
Heading Depth: 3
Heading Rank: 9

Heading: Annual Report, 2006

Text: In the 2006 Annual Report, issued March 29, 2007, the Company issued more extensive risk disclosures. Id. at 55. Those disclosures included that (1) five regional Medicare carriers covering a total of twenty states issued draft local coverage determinations that could adversely affect reimbursement, including several that would not reimburse for NC-Stat procedures under the neurology codes; (2) the AMA Editorial Panel formed a committee to examine coding practices for similar devices; and (3) local coverage determinations and coding articles addressed other issues, including the background and training of physicians performing the tests. Id. The report stated that the company did not believe that the local coverage determinations prohibited physicians from receiving reimbursement for the NC-Stat, but acknowledged that they do appear targeted at limiting access to perform and/or reimbursement for nerve conduction studies. Id. at 56. As with its fourth quarter 2006 statement, this disclosure provides more information about the reimbursement landscape than do the company's earlier statements and reports. We cannot find it to be materially misleading under these circumstances.